financetom
Business
financetom
/
Business
/
PepsiCo Improves Full-Year Earnings Outlook Following Third-Quarter Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PepsiCo Improves Full-Year Earnings Outlook Following Third-Quarter Beat
Oct 9, 2025 6:17 AM

08:59 AM EDT, 10/09/2025 (MT Newswires) -- PepsiCo ( PEP ) issued an improved full-year earnings outlook on Thursday amid easing foreign-exchange headwinds, while the beverage and snacks giant reported better-than-expected fiscal third-quarter results.

The company now anticipates core earnings to decline by 0.5% on a per-share basis in fiscal 2025, compared with its previous projections for a 1.5% decrease. The current consensus on FactSet is for non-GAAP EPS of $8.03. Foreign exchange is expected to negatively impact core EPS growth by about 0.5 percentage points, based on current rates, versus the prior guidance for a headwind of about 1.5 percentage points.

"Our full-year core (US dollar) EPS outlook has improved due to a more favorable outlook on foreign exchange translation rates for the balance of this year," Chief Executive Ramon Laguarta said in a statement. PepsiCo's ( PEP ) shares edged up 1% in the most recent premarket activity.

The company continues to expect a low-single-digit rise in organic revenue for the ongoing fiscal year.

"As we look ahead to the balance of this year and beyond, our top priorities are to accelerate growth and aggressively optimize our cost structure," according to Laguarta. "We are introducing a strong pipeline of innovation to accelerate portfolio transformation, continuously sharpening our price pack architecture to provide good value to consumers, and right sizing our entire cost base to help fund our activities."

For the three-month period ended Sept. 6, PepsiCo's ( PEP ) core EPS moved down to $2.29 from $2.31 the year before, but topped the Street's view for $2.26. Revenue increased to $23.94 billion from $23.32 billion, topping the average analyst estimate on FactSet for $23.84 billion. On an organic basis, revenue improved 1.3%.

Overall net pricing had a positive impact of 4% on the topline, while consolidated organic volume dropped 3%. Volume ticked down 1% each in the company's convenient foods and beverages segments.

"Our reported net revenue growth accelerated and reflects the resilience of our international business, improved momentum within North America beverages and the benefits of our portfolio reshaping actions," Laguarta said.

Revenue in PepsiCo's ( PEP ) North America foods business, which includes Frito-Lay and Quaker Foods, inched down to $6.53 billion from $6.54 billion in the prior-year period. Sales in the North American beverages unit nudged higher to $7.33 billion from $7.18 billion. International beverages revenue remained flat year over year at $1.29 billion.

In a separate statement, the company said it appointed Steve Schmitt as chief financial officer, effective Nov. 10. Schmitt, who currently serves as CFO of Walmart ( WMT ) US, will succeed Jamie Caulfield, who will retire from the group and remain in an advisory role until May 15.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sonoma Pharmaceuticals Gets FDA Clearance for Hydrogel Wound Treatment
Sonoma Pharmaceuticals Gets FDA Clearance for Hydrogel Wound Treatment
Nov 11, 2024
05:39 PM EST, 11/11/2024 (MT Newswires) -- Sonoma Pharmaceuticals ( SNOA ) said late Monday the US Food and Drug Administration has granted a new 510(k) clearance for its Microcyn technology-based hydrogel for wound treatment. The clearance allows the product to be used, under the supervision of a healthcare professional, for wounds associated with dermal irritation, sores, injuries and ulcers...
23andMe cuts 40% of its workforce, discontinues all therapy programs
23andMe cuts 40% of its workforce, discontinues all therapy programs
Nov 11, 2024
Nov 11 (Reuters) - Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and...
Yalla Group Q3 Non-GAAP Earnings, Revenue Increase
Yalla Group Q3 Non-GAAP Earnings, Revenue Increase
Nov 11, 2024
05:51 PM EST, 11/11/2024 (MT Newswires) -- Yalla Group ( YALA ) reported Q3 non-GAAP earnings late Monday of $0.24 per diluted share, up from $0.21 a year earlier. Analyst estimates for EPS were not available for comparison. Revenue in the quarter ended Sept. 30 rose to $88.9 million from $85.2 million a year earlier. Two analysts in a Capital...
Singapore's Grab raises annual revenue forecast, shares jump
Singapore's Grab raises annual revenue forecast, shares jump
Nov 11, 2024
(Reuters) - Singapore's Grab Holdings ( GRAB ) raised its forecast for fiscal 2024 revenue on Monday, as it anticipates robust growth in its food delivery and ride-hailing businesses. U.S.-listed shares of the company jumped over 10% in extended trading. The company expects revenue in the range of $2.76 billion to $2.78 billion, compared with its prior projection of between...
Copyright 2023-2026 - www.financetom.com All Rights Reserved